- Home
- TDS vs KYMR Comparison
TDS vs KYMR Comparison
Compare TDS & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TDS
- KYMR
- Stock Information
- Founded
- TDS 1968
- KYMR 2015
- Country
- TDS United States
- KYMR United States
- Employees
- TDS N/A
- KYMR N/A
- Industry
- TDS Telecommunications Equipment
- KYMR Medicinal Chemicals and Botanical Products
- Sector
- TDS Telecommunications
- KYMR Health Care
- Exchange
- TDS Nasdaq
- KYMR Nasdaq
- Market Cap
- TDS 3.6B
- KYMR 3.0B
- IPO Year
- TDS N/A
- KYMR 2020
- Fundamental
- Price
- TDS $31.17
- KYMR $41.96
- Analyst Decision
- TDS Buy
- KYMR Buy
- Analyst Count
- TDS 2
- KYMR 13
- Target Price
- TDS $45.50
- KYMR $51.15
- AVG Volume (30 Days)
- TDS 1.2M
- KYMR 415.6K
- Earning Date
- TDS 11-01-2024
- KYMR 10-31-2024
- Dividend Yield
- TDS 0.51%
- KYMR N/A
- EPS Growth
- TDS N/A
- KYMR N/A
- EPS
- TDS N/A
- KYMR N/A
- Revenue
- TDS $5,036,000,000.00
- KYMR $87,563,000.00
- Revenue This Year
- TDS N/A
- KYMR N/A
- Revenue Next Year
- TDS N/A
- KYMR $21.47
- P/E Ratio
- TDS N/A
- KYMR N/A
- Revenue Growth
- TDS N/A
- KYMR 86.92
- 52 Week Low
- TDS $13.69
- KYMR $17.89
- 52 Week High
- TDS $34.57
- KYMR $53.27
- Technical
- Relative Strength Index (RSI)
- TDS 62.02
- KYMR 34.56
- Support Level
- TDS $30.38
- KYMR $45.16
- Resistance Level
- TDS $33.10
- KYMR $53.23
- Average True Range (ATR)
- TDS 1.40
- KYMR 2.58
- MACD
- TDS -0.07
- KYMR -0.54
- Stochastic Oscillator
- TDS 55.38
- KYMR 1.66
About TDS Telephone and Data Systems Inc.
Telephone and Data Systems Inc is a diversified telecommunications operator that provides mobile, telephone, and broadband services. The company's segments include UScellular and TDS Telecom. It generates maximum revenue from the UScellular segment.
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a biotechnology company pioneering a transformative new approach to treating previously untreatable diseases. The company is advancing the field of targeted protein degradation, accessing the body's innate protein recycling machinery to degrade dysregulated, disease-causing proteins. Kymera's Pegasus targeted protein degradation platform harnesses the body's natural protein recycling machinery to degrade disease-causing proteins, with a focus on un-drugged nodes in validated pathways currently inaccessible with conventional therapeutics. It is accelerating drug discovery with an unmatched ability to target and degrade intractable proteins and advance new treatment options for patients.